Cargando…
Case Report: ICIs-induced Guillain–Barré syndrome recovered from mycophenolate mofetil
The emergence of immune checkpoint inhibitors (ICIs) has significantly prolonged the survival time of cancer patients. However, it may also lead to various immune-related adverse events (irAEs), including Guillain–Barré syndrome (GBS), a rare type of irAE. Most GBS patients can recover spontaneously...
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10200921/ https://www.ncbi.nlm.nih.gov/pubmed/37223099 http://dx.doi.org/10.3389/fimmu.2023.1132692 |